Commentary on Allen et al. (2020): Cannabis use during pregnancy-the importance of a life-course health disparities framework.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. "I don't need my kid to be high": prioritizing harm reduction when using cannabis during pregnancy.Harm reduction journal · 2024
   Article
2. Prenatal Exposure to Tobacco and Cannabis in Six Race/Ethnicity Groups during the First Three Years after Legalization of Cannabis for Recreational Use in California.International journal of environmental research and public health · 2023
   Article
3. Women's Social Well-Being During Pregnancy: Adverse Childhood Experiences and Recent Life Events.Women's health reports (New Rochelle, N.Y.) · 2022
   Article

Corrections and comments

• Comment on
  Cannabis use and stressful life events during the perinatal period: cross-sectional results from Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2016.2020

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as